Dr. Bedi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
600 N Wolfe St
Baltimore, MD 21287Phone+1 410-955-8964Fax+1 410-614-1411
Education & Training
Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 1990 - 1993
Wayne State University School of MedicineResidency, Internal Medicine, 1987 - 1990
All India Institute of Medical SciencesClass of 1985
Certifications & Licensure
MD State Medical License 1990 - 2016
Publications & Presentations
PubMed
- 52 citationsImmune profiles in primary squamous cell carcinoma of the head and neck.Vassiliki Saloura, Evgeny Izumchenko, Zhixiang Zuo, Riyue Bao, Michael Korzinkin
Oral Oncology. 2019-09-01 - 235 citationsBifunctional immune checkpoint-targeted antibody-ligand traps that simultaneously disable TGFβ enhance the efficacy of cancer immunotherapyRajani Ravi, Kimberly A. Noonan, Vui Pham, Rishi Bedi, Alex Zhavoronkov
Nature Communications. 2018-02-21 - 205 citationsPatient-derived xenografts effectively capture responses to oncology therapy in a heterogeneous cohort of patients with solid tumorsEvgeny Izumchenko, K. Paz, D. Ciznadija, Ido Sloma, Amos Katz
Annals of Oncology. 2017-10-01
Press Mentions
- Biocon Launches Bifunctional Antibody IO Subsidiary Bicara with $40 MillionMarch 15th, 2021
New Cancer Drugs Enable Immune Cells to Fight CancerMarch 5th, 2018
Johns Hopkins Researchers Invent New Technology for Cancer ImmunotherapyMarch 2nd, 2018- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
